Combine [mnob]
pioglitazone [orch, phsu]
Sulfonylurea [orch, phsu]
Metformin [orch, phsu]
Management [ocac]
Type 2 Diabetes [dsyn]
Suggest [idcn]
Fasting [fndg]
Hyperglycemia, Postprandial [fndg]
Essential [qlco]
PREVENT [phsu]
chronic [tmco]
progression [patf]
Diabetes [dsyn]
Complications [patf]
Authors [prog]
conclude [bodm, orch]
Goal [inpr]
Combination Therapy [topp]
Failure [ftcn]
Dietary [food]
Lifestyle changes [socb]
Paper [mnob]
Focus [spco]
pioglitazone [orch, phsu]
Combination [qlco]
Oral [spco]
Antihyperglycemic Agents [phsu]
treatment [ftcn]
Type 2 Diabetes [dsyn]
Interim [tmco]
Efficacy [qlco]
Safety [hcpp]
Combinations [mnob]
sulphonylureas [orch, phsu]
Combination [qlco]
pioglitazone [orch, phsu]
Based [ftcn]
Mechanisms [ftcn]
Action [ftcn]
ADD [mobd]
pioglitazone [orch, phsu]
Metformin [orch, phsu]
Synergistic [qlco]
Combination [qlco]
glucose levels [lbtr]
Controlled [ftcn]
Combination Therapy [topp]
weeks [tmco]
pioglitazone [orch, phsu]
SU [idcn]
Metformin [orch, phsu]
Continued [idcn]
Metabolic [ftcn]
Improvement [cnce]
Adjunctive [topp]
pioglitazone [orch, phsu]
Combination Therapy [topp]
Sustained [ftcn]
Improvement [cnce]
Lipid [lipd]
Profile [lbpr]
Reported [inpr]
pioglitazone [orch, phsu]
Combination [qlco]
SU [idcn]
Metformin [orch, phsu]
Enhance [acty]
glycemia [carb]
Affect [menp]
Lipid [lipd]
Profile [lbpr]
Patients [podg]
Type 2 Diabetes [dsyn]
effects [qlco]
Maintained [ftcn]
Combination Therapy [topp]
SU [idcn]
Metformin [orch, phsu]
Well [qlco]
Drug [phsu]
Hepatotoxicity [inpo]
Continued [idcn]
Improvement [cnce]
glycemia [carb]
Weight Gain [fndg]
3 4 [fndg]
KG [geoa]
Study [mnob]
